• Launch of Parliamentary Allergy Alliance and the National Allergy Strategy - August 2015
  • fp banner 01
  • fp banner 02
  • fp banner 03
  • fp banner 04

Federal Government announces funding of $500k for National Allergy Strategy implementation

The federal government’s funding of the National Allergy Strategy was announced today at the launch of Food Allergy Week 2016 in Sydney, by the Minister for Health, the Hon Sussan Ley MP.

This funding will provide support for the implementation of what has been identified as the three most urgent National Allergy Strategy initiatives:

1. Standardising drug allergy management

There are several issues regarding drug allergy that require urgent attention which will improve patient outcomes, reduce allergy specialist waiting times for more timely access for individuals with more complex diagnosis and management and reduce the use of more expensive antibiotic medications.

The government funding will enable the scoping of drug allergy issues occurring within hospitals and the broader community as well as identify areas of need regarding education for health professionals.

2. Improving allergy management for teens and young adults

Teens and young adults are a high risk group for fatal anaphylaxis. There are limited resources for this group and effective ways of educating are urgently required.

The government funding will provide the opportunity to engage with teens and young adults and determine effective communication and education methods. Urgently needed resources, targeted specifically at teens and young adults will be developed based on the outcomes of these discussions.

3. Allergy management in food service including in the hospital setting.

Whilst we will continue to educate consumers with food allergy on appropriate management and communication when eating food outside the home, the aim of this initiative is to improve the provision of appropriate food to individuals with food allergy, in the food service sector.

The government funding will enable discussions with key stakeholder organisations in the food service sector to identify the most effective methods for improving appropriate food provision for individuals with food allergy. These discussions will help inform and enable education resource development.

Federal Government invests $500k to improve health and quality of life for Australians with allergic diseases

Monday 16 May 2016: 

Strengthening its commitment to improve the health and quality of life of Australians with allergic diseases, the Australian government today announced funding of $500,000 toward Australia’s National Allergy Strategy.

The National Allergy Strategy, launched in August 2015, was developed in partnership by the two leading medical and patient organisations for allergy in Australia - the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA) – and in consultation with some sixty other key stakeholder organisations.

The Turnbull government’s funding boost was announced today at the launch of Food Allergy Week 2016 in Sydney. It will provide support for the implementation of three urgent National Allergy Strategy initiatives:

  • Standardising drug allergy management
  • Improving allergy management for teens and young adults, and
  • Allergy management in food service including in the hospital setting.

Allergic diseases now affect approximately one in five Australians [1]. Food allergy induced anaphylaxis has doubled in the last 10 years with one in 10 infants born in Australia each year - around 30,000 - now having a food allergy [2].

Dr. Richard Loh, Co-chair of the National Allergy Strategy and immediate past President of ASCIA, welcomed today’s funding announcement.

Rationale for the
National Allergy Strategy

Allergic diseases have become an increasingly important chronic disease and public health issue in Australia and other developed countries over the last two decades, contributing to increased demand for medical services, significant economic cost of care and reduced quality of life of people with allergic diseases and their carers. 

Learn more...

Lead Organisations

ascia logo
aaa logo

The Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA) are the leading medical and patient organisations for allergy in Australia. 
Learn more...

Supporting Organisations

Major Supporters of the Allergy Summits and National Allergy Strategy:
Alphapharm | bioCSL | Stallergenes | Bayer
Allergy Summit 2014:
Nestlé Nutrition | Merck Sharp Dohme | Nutricia

The National Allergy Strategy content has not been influenced by supporting organisations that have provided unrestricted educational grants.